Clinical Outcomes in Neovascular Age-related Macular Degeneration with Aflibercept 8 mg in the Phase II CANDELA Study

Jordana G. Fein; Priya S. Vakharia; A. Paul Chous; Rutvi Desai; Fabiana Q. Silva; Kimberly Reed; Alyson J. Berliner; Robert Vitti; Charles C. Wykoff

doi:10.1016/j.oret.2025.03.023

Clinical Outcomes in Neovascular Age-related Macular Degeneration with Aflibercept 8 mg in the Phase II CANDELA Study

Jordana G. Fein, Priya S. Vakharia, A. Paul Chous, Rutvi Desai, Fabiana Q. Silva, Kimberly Reed, Alyson J. Berliner, Robert Vitti, Charles C. Wykoff

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Ophthalmology Retina
DOIs	https://doi.org/10.1016/j.oret.2025.03.023
State	Accepted/In press - 2025

Keywords

Aflibercept
High dose
Neovascular age-related macular degeneration
Vascular endothelial growth factor

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.oret.2025.03.023

Cite this

@article{734126a75e8340d99b64482e8823433a,

title = "Clinical Outcomes in Neovascular Age-related Macular Degeneration with Aflibercept 8 mg in the Phase II CANDELA Study",

keywords = "Aflibercept, High dose, Neovascular age-related macular degeneration, Vascular endothelial growth factor",

author = "Fein, {Jordana G.} and Vakharia, {Priya S.} and Chous, {A. Paul} and Rutvi Desai and Silva, {Fabiana Q.} and Kimberly Reed and Berliner, {Alyson J.} and Robert Vitti and Wykoff, {Charles C.}",

year = "2025",

doi = "10.1016/j.oret.2025.03.023",

language = "English (US)",

journal = "Ophthalmology Retina",

issn = "2468-6530",

publisher = "Elsevier",

}

TY - JOUR

T1 - Clinical Outcomes in Neovascular Age-related Macular Degeneration with Aflibercept 8 mg in the Phase II CANDELA Study

AU - Fein, Jordana G.

AU - Vakharia, Priya S.

AU - Chous, A. Paul

AU - Desai, Rutvi

AU - Silva, Fabiana Q.

AU - Reed, Kimberly

AU - Berliner, Alyson J.

AU - Vitti, Robert

AU - Wykoff, Charles C.

PY - 2025

Y1 - 2025

KW - Aflibercept

KW - High dose

KW - Neovascular age-related macular degeneration

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=105003942093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=105003942093&partnerID=8YFLogxK

U2 - 10.1016/j.oret.2025.03.023

DO - 10.1016/j.oret.2025.03.023

M3 - Article

C2 - 40180316

AN - SCOPUS:105003942093

SN - 2468-6530

JO - Ophthalmology Retina

JF - Ophthalmology Retina

ER -

Clinical Outcomes in Neovascular Age-related Macular Degeneration with Aflibercept 8 mg in the Phase II CANDELA Study

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this